Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Wieliszew – page 2

22 clinical trials in Wieliszew, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Wieliszew at a glance
22
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

22 trials in Wieliszew

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Shanghai Henlius Biotech Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Mitomycin
  • Sponsor:Urogen Pharma Ltd.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Pfizer Inc.
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Capivasertib
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Bicycletx Limited
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Mitomycin
  • Sponsor:Janssen - Cilag International
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Osimertinib
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Novartis Pharma AG
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Doxorubicin
  • Sponsor:Merck Sharp & Dohme LLC
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Wieliszew

What the registry says about research in the country

01 Breast Cancer Research

Comprehensive studies focusing on various types of breast cancer, including extensive research into hormone receptor-positive and triple-negative cases. Multiple trials are evaluating novel combination therapies and treatment approaches.

  • HR+/HER2- Advanced Breast Cancer
  • Triple Negative Breast Cancer (TNBC)
  • Early-Stage Breast Cancer

Current trials are investigating innovative therapeutic combinations and examining the effectiveness of new compounds in both early-stage and metastatic settings.

02 Bladder Cancer Studies

Groundbreaking research exploring treatments for non-muscle invasive bladder cancer, with particular focus on novel intravesical therapies and targeted treatments for specific genetic mutations.

  • High-Risk NMIBC
  • FGFR+ Bladder Cancer
  • Advanced Urothelial Cancer

Studies are evaluating both local and systemic treatments, including immunotherapy combinations for various stages of bladder cancer.

03 Lung Cancer Initiatives

Advanced research programs targeting different types of lung cancer, including specialized studies for small cell and non-small cell variants, with emphasis on targeted therapies and combined treatment approaches.

  • Limited-Stage Small Cell Lung Cancer
  • EGFR-Mutated NSCLC

Trials are investigating post-surgical treatments and combination therapies involving chemotherapy and radiotherapy.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.